Crystal in Iran: Methamphetamine or heroin kerack

DARU, Journal of Pharmaceutical Sciences

Volumn 21, Issue 1, 2013, Pages

  Alam Mehrjerdi, Zahra ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; DIAMORPHINE; METHADONE; METHAMPHETAMINE; MODAFINIL; NALTREXONE;

COGNITIVE THERAPY; DRUG EFFICACY; DYSPNEA; HEART FAILURE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; HYPERTHERMIA; INTOXICATION; INTRAVENOUS DRUG ABUSE; IRAN; MAINTENANCE THERAPY; METHAMPHETAMINE DEPENDENCE; MYDRIASIS; PSYCHOSIS; REVIEW; SINUS TACHYCARDIA; SMOKING; SYSTOLIC DYSFUNCTION; TACHYPNEA;

EID: 84875338895     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-21-22     Document Type: Review

References (25)

1. Brief overview of the status of drug abuse in Iran. Mokri A, Arch Iran Med 2002 5 184 190 Retrieved from sid.ir/En/VEWSSID/J-pdf/86920020312.pdf (Pubitemid 35314992)
2. The drug market in Iran. Raisdana F, Nakhjavani AG, Ann Am Acad Polit Soc Sci 2002 582 149 166 Retrieved from http://bdoc.ofdt.fr/pmb/opac-css/index.php? lvl=notice-display&id=56099 (Pubitemid 36695646)
3. Socio-cultural factors associated with the initiation of opium use in Darab, Iran. Jafari S, Rahimi Movaghar A, Craib K, Baharlou S, Mathias R, Int J Ment Health Addiction 2009 7 376 388 Retrieved from http://link.springer.com/ article/10.1007%2Fs11469-008-9176-y 10.1007/s11469-008-9176-y
4. United Nations Office on Drug and Crime (UNODC), World drug report Vienna: Austria 2011 Retrieved from www. unodc.org//WDR 2011 / World-Drug-Report-2011-ebook.pdf
5. Methamphetamine abuse a new concern in Iran. Mehrpour O, DARU 2012 20 73 PMID: 23351837, PMCID: PMC3556003 10.1186/2008-2231-20-73 23351837
6. Substance abuse among Iranian high school students. Momtazi S, Rawson R, Curr Opin Psychiatry 2010 23 221 226 10.1097/YCO.0b013e328338630d 20308905
7. Approaches to the development of medications for the treatment of methamphetamine dependence. Vocci FJ, Appel NM, Addiction 2007 102 96 106 17493058 (Pubitemid 46328210)
8. Treatments for methamphetamine abuse: a literature review for the clinician. Brackins T, Brahm NC, Kissack JC, J Pharm Pract 2011 24 541 550 10.1177/0897190011426557 22095579
9. Methamphetamine dependence: a closer look at treatment response and clinical characteristics associated with route of administration in outpatient treatment. Rawson RA, Gonzales R, Marinelli-Casey P, Ang A, Am J Addict 2007 16 291 299 10.1080/10550490701389864 17661197 (Pubitemid 47174577)
10. A multi-site comparison of psychosical approaches for the treatment of methamphetamine dependence. Rawson R, Marinelli-Casey P, Anglin MD, Dickow A, Frazier Y, Gallagher C, Galloway GP, Herrell J, Huber A, McCann MJ, Obert J, Pennell S, Reiber C, Vandersloot D, Zweben J, Methamphetamine Treatment Project Corporate Authors, Addiction 2004 99 708 717 10.1111/j.1360-0443.2004.00707.x 15139869 (Pubitemid 38747908)
11. Emergence of a methamphetamine crisis in Iran. Shariatirad S, Maarefvand M, Ekhtiari H, Drug Alcohol Rev 2012 32 223 224 10.1111/dar.12014 23190186
12. Amphetamine use and its associated factors in body builders: a study from Tehran, Iran. Angoorani H, Narenjiha H, Tayyebi B, Ghassabian A, Ahmadi G, Assari S, Arch Med Sci 2012 8 362 367 10.5114/aoms.2012.28566, PMID: 23351837, PMCID: PMC3556003 22662012
13. Methamphetamine dependency. Lashkaripour K, Torbati E, Int J High Risk Behav Addcict 2012 1 7 8 10.5812/ijhrba.5336
14. An emerging trend of methamphetamine injection in Iran: A critical target for research on blood borne infection diseases. Alam mehrjerdi Z, Noroozi AR, Hepat Mon 2013 2 1 3 10.5812/hepatmon.8154
15. Amphetamine psychosis and eye autoenucleation. Omidvar T, Sharifi V, Aust N Z J Psychiatry 2012 46 71 10.1177/0004867411427810 22247101
16. Serotonin syndrome following single ingestion of high dose methamphetamine. Rahmani SH, Ahmadi S, Hasssanian Moghaddam H, Clinical Toxicol 2011 1 3 10.4172/2161-0495.1000111
17. Methamphetamine has changed the profile of patients utilizing psychiatric emergency services in Iran. Zarghami M, Iran J Psychiatr Behav Sci 2011 5 1 5 Retrieved from URL http://ijpbs.mazums.ac.ir/browse.php?a-code=A-10-2- 39&slc-lang=en&sid=1
18. Iranian Crystal: A misunderstanding of the crystal meth. Karrari P, Mehrpour O, Balali-Mood M, J Res Med Sci. 2012 17 203 204 PMID: 23264800, PMCID: PMC3525044 23264800
19. The comparison of demographic characteristics and variety of substances at methadone maintenance clinic of Baharan psychiatry hospital in 2009-2010 [abstract]. Lashkaripour K, Yusefi M, Ghasemi S, Zabihi RT, Abstract book of Fifth Addiction Congress in Zahedan 2012 124 Retrieved from http://bmsunursing. blogfa.com/post-1917.aspx
20. Treatment of methamphetamine abuse: research findings and clinical directions. Cretzmeyer M, Sarrazin MV, Huber DL, Block RI, Hall JA, J Subst Abuse Treat 2003 24 267 277 10.1016/S0740-5472(03)00028-X 12810148 (Pubitemid 37297344)
21. Implications of chronic methamphetamine use: a literature review. Meredith CW, Jaffe C, Ang-Lee K, Saxon AJ, J Harv Rev Psychiatry 2005 13 141 154 10.1080/10673220591003605 (Pubitemid 40967247)
22. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. Scott CJ, Woods SP, Matt GE, Meyer RA, Heaton RK, Atkinson JH, Grant I, Neuropsychol Rev 2007 7 275 297 10.1007/s11065-007-9031-0 (Pubitemid 47498174)
23. Determination of impurities in illicit methamphetamine samples seized in Iran. Khajeamiri AR, Faizi M, Sohani F, Baheri T, Kobarfard F, Forensic Sci Int 2012 217 204 206 10.1016/j.forsciint.2011.11.005 22153622
24. Street-level heroin seizures in Iran: a survey of components. Akhgari M, Jokar F, Bahmanabadi L, Etemadi Aleagha A, J Subst Use 2012 17 348 355 10.3109/14659891.2011.592898
25. Report of methamphetamine use and cardiomyopathy in three patients. Sadeghi R, Agin K, Najm-Afshar L, Nelson LS, Abdollahi M, Shadnia S, DARU 2012 20 20 10.1186/2008-2231-20-20, PMID: 23351936, PMCID: PMC3555706 23351936